Josie Montegaard, NP, shares how nurses can help patients mitigate and manage negative CLL treatment side effects.
Leukemia
Review the most current news and learn about the latest clinical developments in leukemia care. Cancer Nursing Today has up-to-date perspectives and information on treatment of acute myeloid leukemia, whole-genome sequencing for myeloid cancers, and more. Discover how the latest clinical trials and research are impacting patient care for all forms of leukemia.
Advertisement
Researchers analyzed clinical outcomes because hematopoietic SCT is becoming more a more accessible and utilized treatment.
Research presented at the NCCN Annual Conference illuminated patient experiences with tyrosine kinase inhibitors.
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
A study presented at the NCCN Annual Conference shed light on the perspectives of patients and healthcare professionals.
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
The clinically focused intervention invovled a symptom assessment questionnaire followed by symptom support.
The CLL12 trial included patients with treatment-naive, asymptomatic, early-stage chronic lymphocytic leukemia.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.